232 related articles for article (PubMed ID: 6848749)
1. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
Vu VT; Bai SA; Abramson FP
J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
[TBL] [Abstract][Full Text] [Related]
2. Interaction of phenobarbital with propranolol in the dog. 3. Beta blockade.
Bai SA; Abramson FP
J Pharmacol Exp Ther; 1983 Jan; 224(1):62-7. PubMed ID: 6129320
[TBL] [Abstract][Full Text] [Related]
3. Interactions of phenobarbital with propranolol in the dog. 1. Plasma protein binding.
Bai SA; Abramson FP
J Pharmacol Exp Ther; 1982 Sep; 222(3):589-94. PubMed ID: 7108766
[TBL] [Abstract][Full Text] [Related]
4. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
Branch RA; Shand DG; Wilkinson GR; Nies AS
J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective increase in propranolol bioavailability during chronic dosing in the dog.
Bai SA; Wilson MJ; Walle UK; Walle T
J Pharmacol Exp Ther; 1983 Nov; 227(2):360-4. PubMed ID: 6631718
[TBL] [Abstract][Full Text] [Related]
6. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
Lankford SM; Maskasame C; Bai SA
Drug Metab Dispos; 1994; 22(5):776-87. PubMed ID: 7835231
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of propranolol in the dog.
Tse FL; Sanders TM; Reo JP
Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):180-9. PubMed ID: 7224706
[TBL] [Abstract][Full Text] [Related]
8. Interaction between oral hydralazine and propranolol. I. Changes in absorption, presystemic clearance and splanchnic blood flow.
Heinzow B; Corbett H; Constantinides S; Bourne R; McLean AJ
J Pharmacol Exp Ther; 1984 May; 229(2):509-14. PubMed ID: 6716273
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of propranolol: a review.
Shand DG
Postgrad Med J; 1976; 52 Suppl 4():22-25. PubMed ID: 787953
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique.
Walle T; Walle UK
Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):453-64. PubMed ID: 461970
[TBL] [Abstract][Full Text] [Related]
11. Effect of experimental renal failure on the disposition kinetics of l-propranolol in rats.
Terao N; Shen DD
J Pharmacol Exp Ther; 1983 Nov; 227(2):295-301. PubMed ID: 6631714
[TBL] [Abstract][Full Text] [Related]
12. Effects of route of administration and blood flow on hepatic drug elimination.
Shand DG; Kornhauser DM; Wilkinson GR
J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of single doses of phenobarbital given intravenously and orally to dogs.
Pedersoli WM; Wike JS; Ravis WR
Am J Vet Res; 1987 Apr; 48(4):679-83. PubMed ID: 3592366
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and interactions of digoxin with phenobarbital in dogs.
Ravis WR; Pedersoli WM; Turco JD
Am J Vet Res; 1987 Aug; 48(8):1244-9. PubMed ID: 3631715
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and metabolism of oral doses of a 4'-methylthio derivative of propranolol in man.
Walle T; Walle UK; Cowart TD; Conradi EC; Gaffney TE
Xenobiotica; 1990 Mar; 20(3):321-31. PubMed ID: 2336841
[TBL] [Abstract][Full Text] [Related]
16. The effect of phenobarbital and SKF 525A on tocainide pharmacokinetics in the rat.
Venkataramanan R; Axelson JE
J Pharmacol Exp Ther; 1980 Oct; 215(1):235-9. PubMed ID: 6778991
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic phenobarbital on verapamil disposition in humans.
Rutledge DR; Pieper JA; Mirvis DM
J Pharmacol Exp Ther; 1988 Jul; 246(1):7-13. PubMed ID: 3392664
[TBL] [Abstract][Full Text] [Related]
18. In vivo effects of the cytochrome P-450 suicide substrate 2-isopropyl-4-pentenamide (allylisopropylacetamide) on the disposition and metabolic pattern of propranolol.
Silber B; Mico BA; Ortiz de Montellano PR; Dols DM; Riegelman S
J Pharmacol Exp Ther; 1981 Oct; 219(1):125-33. PubMed ID: 7288600
[No Abstract] [Full Text] [Related]
19. Effect of enzyme induction on the disposition of lorcainide in rats following intravenous and oral administration.
Plänitz V; Jähnchen E
Arzneimittelforschung; 1984; 34(6):669-71. PubMed ID: 6541487
[TBL] [Abstract][Full Text] [Related]
20. Lack of gastrointestinal metabolism of propranolol in dogs after portacaval transposition.
Lo MW; Effeney DJ; Pond SM; Silber BM; Riegelman S
J Pharmacol Exp Ther; 1982 May; 221(2):512-5. PubMed ID: 7077541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
